We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current GRTX market cap is 10.46M. The company's latest EPS is USD -1.0862 and P/E is -0.18.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.96M | -13.16M | -13.88M | -16.81M | -13.4M |
| Net Income | -16.03M | -16.19M | -17.71M | -20.71M | -15.07M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -50.69M | -70.55M | -73.37M | -51.23M | -49.26M |
| Net Income | -59.11M | -74.22M | -80.53M | -62.22M | -59.08M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 50.71M | 44.04M | 59.71M | 48.28M | 37.78M |
| Total Liabilities | 148.22M | 153.22M | 157.33M | 163.28M | 164.33M |
| Total Equity | -97.5M | -109.18M | -97.61M | -115M | -126.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 123.38M | 84.1M | 83.31M | 44.04M | 26.14M |
| Total Liabilities | 53.77M | 77.98M | 141.32M | 153.22M | 157.33M |
| Total Equity | 69.61M | 6.12M | -58M | -109.18M | -131.19M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.48M | -43.43M | -11.67M | -22.41M | -34.93M |
| Investing | 21.22M | 23.99M | 5.31M | 12.85M | 23.32M |
| Financing | 1.19M | 3.89M | 27.78M | 29.59M | 31.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -46.66M | -59.54M | -67.96M | -43.43M | -44.85M |
| Investing | -27.83M | 36.55M | 5.24M | 23.99M | 27.29M |
| Financing | 78.03M | 20.51M | 66.71M | 3.89M | 31.5M |
| Market Cap | 10.46M |
| Price to Earnings Ratio | -0.18 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.6 |
| Price to Book Ratio | -0.08 |
| Dividend Yield | - |
| Shares Outstanding | 54.39M |
| Average Volume (1 week) | 882.32k |
| Average Volume (1 Month) | 1.78M |
| 52 Week Change | -94.05% |
| 52 Week High | 3.59 |
| 52 Week Low | 0.0853 |
| Spread (Intraday) | 0.01 (2.59%) |
| Company Name | Galera Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.galeratx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
